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The medium‑chain fatty acid 
decanoic acid reduces oxidative 
stress levels in neuroblastoma cells
Janine Mett* & Uli Müller 
Enhanced oxidative stress is a contributing factor in the pathogenesis of several neurodegenerative 
disorders such as Alzheimer´s disease. Beneficial effects have been demonstrated for medium‑chain 
fatty acids (MCFAs) nutritionally administered as medium‑chain triglycerides (MCTs) or coconut oil 
(CO). The observed effects on cognitive impairment are generally attributed to the hepatic metabolism 
of MCFAs, where resulting ketone bodies serve as an alternate energy source to compensate for the 
impaired glucose utilisation in the human brain. Here we show that the saturated MCFA decanoic acid 
(10:0) reduces the oxidative stress level in two different neuroblastoma cell lines. Phosphatidylcholine 
(PC) containing decanoic acid (10:0) (PC10:0/10:0) reduced the cellular  H2O2 release in comparison 
to solvent, L‑α‑Glycerophosphorylcholine and PC containing the long‑chain fatty acid (LCFA) 
arachidic acid (20:0). This effect seems to be at least partially based on an upregulation of catalase 
activity, independent of alterations in catalase gene expression. Further, PC10:0/10:0 decreased the 
intracellular oxidative stress level and attenuated the  H2O2‑induced cell death. It did not affect the 
level of the ketone body β‑hydroxybutyrate (βHB). These results indicate that decanoic acid (10:0) and 
possibly MCFAs in general directly reduce oxidative stress levels independent of ketone levels and thus 
may promote neuronal health.
Oxidative stress is defined as ‘an imbalance in pro-oxidants and antioxidants with associated disruption of redox 
circuitry and macromolecular damage’1. It results in elevated levels of reactive oxygen and nitrogen species (ROS, 
RNS) including  O2•− (superoxide radical anion),  OH• (hydroxyl radical),  H2O2 (hydrogen peroxide), •NO (nitric 
oxide) and  ONOO− (peroxynitrite)2. ROS are physiologically derived from the mitochondrial electron transport 
chain and the activity of NADPH oxidases (NOXs) transferring electrons from NADPH across cellular mem-
branes to molecular oxygen. The main ROS generated by NOX isoenzymes is  O2•−, NOX4 predominantly releases 
 H2O2.  O2•− is rapidly converted to  H2O2 by superoxide dismutases (SODs) or to  OH•. Cellular proportion of ROS 
generation and detoxification by antioxidant enzymes such as SODs, glutathione peroxidase (GPx) and catalase 
determines the ROS  level2–5. Although ROS and in particular  H2O2 might function in various signal transduction 
pathways, excessive levels of these free radicals are  hazardous5. Oxidative damage of proteins, lipids and nucleic 
acids may eventually result in cellular degeneration, functional decline and cell death. The brain is particularly 
susceptible to oxidative injuries owed to its limited antioxidant capacity, its high energy demand and its high 
content of polyunsaturated fatty acids (PUFAs). Increased oxidative stress has been identified as a contributing 
factor in the pathogenesis of several neurodegenerative disorders, for example Alzheimer´s disease. Thus, the 
reduction of cerebral ROS level might help to slow down the progression of these  diseases2,6,7.
Medium-chain fatty acids (MCFAs) are saturated fatty acids consisting of 6 to 12 carbon atoms. Natural 
dietary sources of these fatty acids are coconut oil (CO) and palm kernel oil with 62–70% MCFAs of the satu-
rated fatty acid portion (> 90%). In contrast to other fatty acids MCFAs are easily absorbed and metabolized 
within liver mitochondria to produce the ketone bodies 3-β-hydroxybutyrate (βHB), acetoacetic acid (AcAc) 
and acetone (Ac)8–11. As they can be converted to acetyl-CoA, a key substrate in the citric acid cycle to provide 
ATP, ketone bodies can improve the cerebral energy metabolism during periods with limited glucose availability 
or  uptake10,12. Nutritional studies in patients with minor to moderate cognitive impairment suggest the daily 
consumption of MCFAs, in the form of CO or medium-chain triglycerides (MCTs) to have beneficial effects. 
The observed effects are generally attributed to the elevation of circulating ketone bodies compensating for the 
cerebral glucose hypometabolism in patients suffering from Alzheimer´s  disease8,9,13–23. In this context Wang 
et al. showed MCFAs and especially 10-carbon length MCTs to have neuroprotective and cognition-enhancing 
properties in aged Wistar rats, independent of brain ketone  levels24.
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In recent in vitro studies CO as well as pure MCFAs were found to protect primary cortical neurons from 
amyloid-β (Aβ)-induced toxicity. CO was demonstrated to diminish markers of oxidative stress in these  cells25,26. 
Similarly, ketone bodies metabolically derived from CO and MCFAs have been reported to prevent oxidative 
injury in primary neurons and in SH-SY5Y  cells27,28. Although advances in understanding the mechanisms of 
MCFA-action have more recently shifted attention away from ketone bodies to the direct role of fatty  acids29, the 
effect of MCFAs on the oxidative stress level of neuronal cells is largely unknown. This prompted us to investigate 
the impact of the MCFA decanoic acid (10:0) on ROS levels in two different neuroblastoma cell lines, in which 
ketogenesis is assumed to be  absent30.
Results
The MCFA decanoic acid (10:0) reduces  H2O2 release from neuroblastoma cells. In order to 
analyze whether the MCFA decanoic acid (10:0) influences the oxidative stress level in neuronal cells, we treated 
neuroblastoma cells with 10 µM of the most abundant phospholipid in mammalian cellular  membranes31, phos-
phatidylcholine (PC) containing decanoic acid (10:0) in the sn-1 and sn-2 position (1,2-didecanoyl-sn-glycero-
3-phosphocholine, PC10:0/10:0). Control cells were treated with the solvent ethanol (EtOH) (set as 100%). As 
an additional reference we used PC containing the long-chain fatty acid (LCFA) arachidic acid (20:0) (1,2-Di-
arachidoyl-sn-glycero-3-phosphocholine, PC20:0/20:0, final concentration 10  µM). This setup allowed us to 
determine the sole effect of the fatty acid chain length.
10 µM final concentration of the lipids reflects the plasma 10:0-concentration in rats fed a MCT-enriched diet 
(5% MCT containing decanoic acid (10:0)) for 8  weeks24. In order to lower the lipid content of the medium and 
to inhibit cell proliferation, the concentration of fetal calf serum (FCS) in the cell culture medium was reduced 
to 0.1% during the phospholipid treatment.
After 18 h (hours) treatment, for one the level of  H2O2 accumulating in the medium during the treatment 
was measured by adding Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) and horseradish peroxidase (HRP) 
to the removed cell culture supernatant. In the presence of peroxidase, the Amplex Red reagent reacts stoichio-
metrically with  H2O2 in a 1:1 ratio to produce the red-fluorescent oxidation product  resorufin32. The outcomes 
of this assay reflect the extracellular steady state level of  H2O2, which is dependent on the generation, flux and 
removal rate of  H2O2 within the 18 h of treatment. Secondly the  H2O2-release-activity of the cells was directly 
measured after supernatant removal and replacement with supplement-free medium containing the reactants 
Amplex Red and HRP.
Our results revealed a significant reduction of the  H2O2 level in the conditioned medium for human SH-SY5Y 
cells treated with PC10:0/10:0 in comparison to solvent (p = 1.47 ×  10–7) and to PC20:0/20:0 (p = 1.61 ×  10–4). 
PC20:0/20:0 had no significant effect on the extracellular  H2O2 content compared to solvent (p = 0.065) (Fig. 1a). 
In order to verify this effect by another cell model, the experiment was replicated utilizing the murine neuro-
blastoma cell line Neuro2a. The effects were even more pronounced in the murine cells (PC10:0/10:0 vs. solvent: 
p < 1 ×  10–14; PC10:0/10:0 vs. PC20:0/20:0: p < 1 ×  10–14) (Fig. 1b). To rule out any interference between the added 
agents and the measured fluorescence or the HRP-catalyzed reaction of Amplex Red with  H2O2, the experiment 
was repeated in a  H2O2-supplemented, cell-free medium. There was no indication for fluorescence quenching or 
an inhibitory effect of PC10:0/10:0 on the reaction itself in the cell-free system. The detected fluorescence signal 
slightly increased in presence of this phospholipid compared to solvent (p = 0.020) and PC20:0/20:0 (p = 0.004) 
(Supplementary Fig. S1). Consequently, the observed effects of PC10:0/10:0 on the extracellular  H2O2 level 
(Fig. 1a,b) are exclusively due to the presence of cells.
The  H2O2-release measurement in the replacement medium showed that pretreatment of SH-SY5Y cells with 
PC10:0/10:0 significantly suppressed the natural release of  H2O2 in comparison to both solvent (p < 1 ×  10–14) and 
PC20:0/20:0 (p < 1 ×  10–14). Again,  H2O2 release did not differ between cells pretreated with solvent or PC20:0/20:0 
(p = 0.943) (Fig. 1c). As shown in Fig. 1d, the effect of PC10:0/10:0 on  H2O2 release could be verified in the murine 
Neuro2a cells (PC10:0/10:0 vs. solvent: p = 9.55 ×  10–6; PC10:0/10:0 vs. PC20:0/20:0: p < 1 ×  10–14). There was 
also a slight, but significant increase of  H2O2 release in Neuro2a cells preincubated with PC20:0/20:0 compared 
to solvent (p = 0.004). Accordingly, PC10:0/10:0 reduces the  H2O2 release of both SH-SY5Y and Neuro2a cells 
resulting in a declined steady state level of  H2O2 in the conditioned cell culture supernatant (Fig. 1a,b).
In order to investigate a dose-dependence of the observed effects, SH-SY5Y cells were pretreated with increas-
ing concentrations of PC10:0/10:0 and PC20:0/20:0 ranging from 1 to 10 µM with a constant EtOH concentration 
of 0.2%. PC10:0/10:0 suppressed the cellular  H2O2 release in a dose-dependent manner.  H2O2 release was found 
to be unaffected by a final PC10:0/10:0 concentration of 1 µM (1 µM PC10:0/10:0 vs. solvent: p = 0.997; 1 µM 
PC10:0/10:0 vs. 1 µM PC20:0/20:0: p = 0.075), while 3 µM and 10 µM PC10:0/10:0 significantly reduced the cel-
lular  H2O2 release compared to both solvent (3 µM: p = 0.012, 10 µM: p < 1 ×  10–14) and the identical concentra-
tion of PC20:0/20:0 (3 µM: p = 2.74 ×  10–4, 10 µM: p = 1.84 ×  10–8) (Fig. 1e). As an additional control the impact 
of l-α-Glycerophosphorylcholine on the cellular  H2O2 release was measured. l-α-Glycerophosphorylcholine 
represents the PC head group and the glycerol backbone without attached fatty acids. While the level of  H2O2 
released by SH-SY5Y cells was unaffected by 10 µM l-α-Glycerophosphorylcholine compared to solvent 
(p = 0.891), it was significantly reduced by 10 µM PC10:0/10:0 compared to solvent (p < 1 ×  10–14), 10 µM l-α-
Glycerophosphorylcholine (p < 1 ×  10–14) and 10 µM PC20:0/20:0 (p < 1 ×  10–14) (Fig. 1f). These data confirm that 
the observed effects of PC10:0/10:0 on  H2O2 release are due to the esterified decanoic acid (10:0).
For a more detailed characterisation of the PC10:0/10:0-effect on cellular  H2O2 release, cells were respectively 
pretreated shortly. As shown in Fig. 1g, 30 min (minutes) short-term incubation of SH-SY5Y cells with 10 µM 
PC10:0/10:0, 10 µM PC20:0/20:0 or solvent did not affect the level of  H2O2 released by the cells (PC10:0/10:0 vs. 
solvent: p = 0.262; PC10:0/10:0 vs. PC20:0/20:0: p = 0.231).
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Figure 1.  Impact of PC10:0/10:0, PC20:0/20:0 or solvent on the extracellular  H2O2 level and  H2O2 release. Cells were 
incubated with the solvent EtOH (0.2%) (set as 100%), PC10:0/10:0, PC20:0/20:0 (10 µM except for e) for 18 h (except for g) 
before  H2O2 accumulating in the medium during the treatment and  H2O2 release was measured by using Amplex Red (5 µM) 
and HRP (0.01 U/ml). 10 µM L-α-Glycerophosphorylcholine was used as an additional reference (f, 10 µM).  H2O2 level in the 
conditioned medium of (a) SH-SY5Y cells (n = 12) and (b) Neuro2a cells (n = 8).  H2O2 released by (c) SH-SY5Y cells (n = 28), 
(d) Neuro2a cells (n = 8), (e) SH-SY5Y cells treated with the solvent EtOH (0.2%) or different concentrations (1, 3 and 10 µM) 
of PC10:0/10:0 or PC20:0/20:0 (n ≥ 6), (f) SH-SY5Y cells additionally treated with 10 µM l-α-Glycerophosphorylcholine as 
reference (n = 6) and (g) SH-SY5Y cells after short-term treatment for 30 min (n = 14). Error bars represent SEM. Asterisks 
show the statistical significance calculated by one-way ANOVA followed by post hoc testing using Tukey’s test (* p ≤ 0.05, ** 
p ≤ 0.01 and *** p ≤ 0.001). Figure was created using Origin Pro 2020b and CorelDRAW Graphics Suite 2020.
4
Vol:.(1234567890)
Scientific Reports |         (2021) 11:6135  | https://doi.org/10.1038/s41598-021-85523-9
www.nature.com/scientificreports/
The MCFA decanoic acid (10:0) reduces intracellular ROS levels in neuroblastoma cells and 
attenuates  H2O2‑induced cell death. H2O2 as small, uncharged molecule crosses cellular membranes 
by simple diffusion and facilitated diffusion through aquaporin (AQP)  85,33. Accordingly, the suppressed  H2O2 
release and the reduced extracellular  H2O2 level of cells treated with PC10:0/10:0 (Fig.  1) might indicate an 
altered intracellular oxidative stress level. Therefore, the intracellular ROS level was assessed by using the Cell-
ROX Green Reagent, which is weakly fluorescent in a reduced state, but exhibits a strong fluorogenic signal upon 
oxidation by ROS and subsequent binding to deoxyribonucleic acid (DNA).
In SH-SY5Y cells pretreated with PC10:0/10:0 the intracellular ROS content was significantly reduced com-
pared to solvent (p < 1 ×  10–14) and PC20:0/20:0 (p = 1.35 ×  10–5). Again, there was no difference between cells 
incubated with solvent or PC20:0/20:0 (p = 0.058) (Fig. 2a). In line with this, a significant reduction of the intra-
cellular ROS level was also observed for Neuro2a cells pretreated with PC10:0/10:0 compared to both references 
(PC10:0/10:0 vs. solvent: p = 1.29 ×  10–3; PC10:0/10:0 vs. PC20:0/20:0: p = 0.023) (Fig. 2b).
The reduction of intracellular ROS content by PC10:0/10:0 might have neuroprotective effects as exces-
sive ROS levels are associated with the oxidative damage of cellular components and the disruption of cellular 
 integrity5. Co-treatment with PC10:0/10:0 indeed protected SH-SY5Y cells from  H2O2-induced cell death. The 
viability of SH-SY5Y cells exposed to 500 µM  H2O2 for 18 h decreased significantly (p = 1.96 ×  10–5) compared to 
control. Co-treatment with PC10:0/10:0 increased viability significantly compared to solvent and PC20:0/20:0 
(PC10:0/10:0 +  H2O2 vs. solvent +  H2O2: p = 0.015; PC10:0/10:0 +  H2O2 vs. PC20:0/20:0 +  H2O2: p = 0.014) (Fig. 2c).
The MCFA decanoic acid (10:0) does not affect cell number and viability. To rule out signal falsi-
fications by general alterations in the number of cells due to treatment procedure, the signal of 4′,6-diamidino-
2-phenylindole (DAPI)-labeled nuclei was measured in each well used for the Amplex Red  H2O2 and CellROX 
Figure 2.  Impact of PC10:0/10:0, PC20:0/20:0 or solvent on the intracellular ROS level and  H2O2-induced 
cytotoxicity. Cells were incubated with the solvent EtOH (0.2%) (set as 100%), PC10:0/10:0 or PC20:0/20:0 
(10 µM) in absence (a,b) or presence (c) of 500 µM  H2O2 for 18 h before intracellular ROS level and  H2O2-
induced changes in cell viability were examined. Intracellular ROS level measured by using CellROX Green in 
(a) SH-SY5Y cells (n = 13) and (b) Neuro2a cells (n = 12). (c)  H2O2-induced changes in the viability of SH-SY5Y 
cells determined by labeling dead cells with propidiumiodide (n = 4). Error bars represent SEM. Asterisks show 
the statistical significance calculated by one-way ANOVA followed by post hoc testing using Tukey’s test (* 




Scientific Reports |         (2021) 11:6135  | https://doi.org/10.1038/s41598-021-85523-9
www.nature.com/scientificreports/
Green assays shown above (Fig. 1a–e, Fig. 2a,b). DAPI exhibits a strong fluorescence enhancement upon binding 
to adenine–thymine-rich regions in the DNA, which correlates with the total number of cells in each well. There 
were no indications for an effect of PC10:0/10:0 compared to solvent and PC20:0/20:0 on total cell numbers 
neither for SH-SY5Y nor for Neuro2a cells (Table 1). Similar results were found for the short-term (30 min) 
pretreatment of SH-SY5Y cells (Supplementary Table S1a). Total cell numbers did also not differ between SH-
SY5Y cells incubated with PC10:0/10:0 or l-α-Glycerophosphorylcholine for 18 h (Supplementary Table S1a).
The performed DAPI staining indicates the total number of nuclei, but does not allow a differentiation 
between living and dead cells. Therefore, following 18 h incubation with solvent, 10 µM PC10:0/10:0 or 10 µM 
PC20:0/20:0 cells were additionally stained with Ethidium homodimer-1, revealing dead cells with a compro-
mised membrane integrity. The number of dead cells was close to equal in all treatments for both cell lines 
(Table 1).
Thus, the observed effects of PC10:0/10:0 on  H2O2 release and intracellular ROS levels cannot be traced to 
alterations in the proliferation or viability of the used cells.
The MCFA decanoic acid (10:0) does not affect βHB levels in neuroblastoma cells. MCFAs are 
quickly metabolized into ketone bodies after their dietary intake, in contrast to  LCFAs22. Ketogenesis occurs 
primarily in the mitochondria of liver cells, but also in some other cell types including  astrocytes10,34. It is a pro-
cess assumed to take place ‘only under very particular physiological circumstances, which are absent in cancer 
cells’30. Accordingly, the use of neuroblastoma cells should allow us to determine the sole effect of the supple-
mented fatty acids. In order to verify this assumption we measured the level of βHB, the most abundant ketone 
body in  mammals12, in the medium and in the homogenates of cells treated with 10 µM PC10:0/10:0, 10 µM 
PC20:0/20:0 or solvent for 18 h. βHB was detectable within these samples. The intracellular βHB level was found 
to be unaffected by the different treatments in SH-SY5Y and Neuro2a cells (Fig. 3a,b, Supplementary Table S2a). 
The βHB content in the cell culture supernatant of the same wells did also not differ between cells treated with 
PC10:0/10:0, PC20:0/20:0 or solvent for both SH-SY5Y and Neuro2a cells (Fig. 3c,d, Supplementary Table S2a). 
The total protein content of the homogenates did not vary depending on the different treatments (Supplemen-
tary Table S3a). These results indicate the effects of PC10:0/10:0 on  H2O2 release and intracellular oxidative stress 
levels not to be based on an increased metabolism of decanoic acid (10:0) into ketone bodies, but rather on direct 
cellular effects of this MCFA.
The MCFA decanoic acid (10:0) increases catalase activity in SH‑SY5Y cells, but not its gene 
expression. Cellular ROS levels are dependent on the balance between their production and their detoxi-
fication by antioxidant  enzymes2–5. In order to investigate whether ROS-detoxification is affected by decanoic 
acid (10:0), the activity of catalase, SOD and GPx in SH-SY5Y and Neuro2a cells incubated with PC10:0/10:0, 
PC20:0/20:0 or solvent for 18 h was measured. The total protein content of the used homogenates was close to 
equal in all treatments for both cell lines (Supplementary Table S3b). Catalase activity was significantly elevated 
in SH-SY5Y cells treated with 10 µM PC10:0/10:0 compared to both solvent (p = 6.02 ×  10–5) and PC20:0/20:0 
(p = 0.008). In contrast, SOD- and GPx-activity was unaffected by the different treatments in this cell line (Fig. 4a, 
Table 1.  Impact of PC10:0/10:0, PC20:0/20:0 or solvent on total cell numbers and cell viability. Total cell 
number (%): DAPI signal correlating with total cell number of all wells used for the measurements shown in 
Figs. 1a–e and 2a,b. Dead cells (%): the percentage of dead cells after treatment with the solvent EtOH (0.2%), 
PC10:0/10:0 or PC20:0/20:0 (10 µM) for 18 h was calculated after determination of the total cell number and 
the number of dead cells utilizing DAPI (1 µg/ml) and Ethidium homodimer-1 (10 µM), respectively. The 
statistical significance was calculated by one-way ANOVA followed by post hoc testing using Tukey’s test, no 
significant differences were observed. SEM standard error of the mean, SD standard deviation.
Total cell number (%)
SH-SY5Y Neuro2a
Solvent PC10:0/10:0 PC20:0/20:0 Solvent PC10:0/10:0 PC20:0/20:0
Mean 100.0 103.4 101.6 100.0 96.9 94.7
SEM 2.2 1.8 1.8 1.9 2.2 2.9
Number of independent experiments (n) 53 51 51 24 24 24
p-value solvent vs. PC10:0/10:0 0.424 0.623
p-value solvent vs. PC20:0/20:0 0.825 0.265
p-value PC10:0/10:0 vs. PC20:0/20:0 0.789 0.799
Dead cells (% of total cells)
SH-SY5Y Neuro2a
Solvent PC10:0/10:0 PC20:0/20:0 Solvent PC10:0/10:0 PC20:0/20:0
Mean 2.7 2.4 3.3 7.5 8.4 7.3
SD 1.4 1.0 1.2 2.4 4.6 2.4
Number of independent experiments (n) 8 8 7 8 8 7
p-value solvent vs. PC10:0/10:0 0.891 0.853
p-value solvent vs. PC20:0/20:0 0.644 0.992
p-value PC10:0/10:0 vs. PC20:0/20:0 0.386 0.800
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Supplementary Table S2b). Thus, the PC10:0/10:0-mediated suppression of  H2O2-release in SH-SY5Y cells might 
be at least partially based on an upregulation of catalase activity. In Neuro2a cells incubated with PC10:0/10:0 
the activity of none of the three analyzed enzymes was significantly altered (Fig. 4b, Supplementary Table S2b).
Hughes et al. reported an upregulation of catalase activity in SH-SY5Y cells after long term-exposure to 
250 µM decanoic acid (10:0) as free fatty acid (FFA). This elevation has been ascribed to a peroxisome prolif-
erator-activated receptor (PPAR) γ-dependent increase in catalase gene  expression35. Accordingly, we investi-
gated whether PC10:0/10:0 similarly affects the enzyme under the conditions chosen in the present study. For 
this purpose, SH-SY5Y cells were treated with 10 µM PC10:0/10:0, PC20:0/20:0 or solvent in the presence or 
absence of two different PPARγ antagonists, Bisphenol A diglycidyl ether (BADGE) and  GW966236,37. While 
the total cell numbers were not affected by BADGE, they were slightly decreased after treatment with GW9662 
(Supplementary Table S1b). Both PPARγ antagonists did not prevent or attenuate the PC10:0/10:0-mediated 
reduction in  H2O2 release (Fig. 4c, Supplementary Table S2c). These data indicate that the suppression of  H2O2 
release in SH-SY5Y cells treated with PC10:0/10:0 is independent of PPARγ activation. PC10:0/10:0 also sig-
nificantly reduced the level of  H2O2 released by SH-SY5Y cells irrespective of the presence of cycloheximide 
and puromycin, two inhibitors of protein  biosynthesis38–41 (Fig. 4d, Supplementary Table S2c), although both 
inhibitors significantly affected total cell numbers (Supplementary Table S1b). In line with these results, reverse 
transcription polymerase chain reaction (RT-PCR), using two different CAT primer pairs and two different 
housekeeping genes for normalization, revealed no differences in CAT gene expression in SH-SY5Y cells treated 
with PC10:0/10:0 compared to solvent and PC20:0/20:0 (Fig. 4e, Supplementary Tables S2d + S4). In conclusion, 
the increase of catalase activity in SH-SY5Y cells incubated with PC10:0/10:0 seems to be not based on altera-
tions in CAT gene expression.
Figure 3.  Impact of PC10:0/10:0, PC20:0/20:0 or solvent on the intra- and extracellular βHB level. Cells were 
incubated with the solvent EtOH (0.2%) (set as 100%), PC10:0/10:0 or PC20:0/20:0 (10 µM) for 18 h before the 
level of βHB was measured by using the β-Hydroxybutyrate (Ketone Body) Colorimetric Assay Kit. βHB level 
in the homogenates of (a) SH-SY5Y cells (n = 8) and (b) Neuro2a cells (n ≥ 5). βHB level in the conditioned 
medium of (c) SH-SY5Y cells (n = 8) and (d) Neuro2a cells (n ≥ 5). Error bars represent SD. The statistical 
significance was calculated by one-way ANOVA followed by post hoc testing using Tukey’s test, no significant 
differences were observed. Figure was created using Origin Pro 2020b and CorelDRAW Graphics Suite 2020.
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Figure 4.  Impact of PC10:0/10:0, PC20:0/20:0 or solvent on the activity of antioxidative enzymes and on catalase gene 
expression. Cells were incubated with the solvent EtOH (0.2%) (set as 100%), PC10:0/10:0, PC20:0/20:0 (10 µM) for 18 h 
in absence (a,b,e) or presence of PPARγ antagonists (c) and inhibitors of protein biosynthesis (d). Catalase, GPx and SOD 
activity in the homogenates of (a) SH-SY5Y cells (catalase: n ≥ 5, GPx: n ≥ 5, SOD: n ≥ 6) and (b) Neuro2a cells (catalase: n ≥ 6, 
GPx: n ≥ 5, SOD: n ≥ 6) determined by using the corresponding enzyme activity assay kits. The activity level of the respective 
enzyme in untreated cells is indicated by a dotted line.  H2O2 released by SH-SY5Y cells measured by using Amplex Red (5 µM) 
and HRP (0.01 U/ml) after treatment with phospholipids or solvent along with (c) 5 µM BADGE / 5 µM GW9662/ DMSO 
(n ≥ 4) and (d) 20 µM cycloheximide/ 2 µM puromycin/ DMSO (n ≥ 5). (e) Catalase gene (CAT ) expression in SH-SY5Y cells 
measured by RT-PCR using two different CAT primer pairs and two different house keeping genes (ACTB: β-actin, TBP: 
TATA-binding protein) for normalization (n = 7). Error bars represent SD (a,b,e) or SEM (c,d). Asterisks show the statistical 
significance calculated by one-way ANOVA followed by post hoc testing using Tukey’s test (** p ≤ 0.01 and *** p ≤ 0.001). 
Figure was created using Origin Pro 2020b and CorelDRAW Graphics Suite 2020.
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Discussion
The beneficial effects of dietary MCFAs for cognitively impaired patients have been mainly attributed to their 
hepatic metabolism resulting in elevated levels of circulating ketone bodies, which positively affect cerebral 
energy  metabolism8,9,13–23. In the present study we showed that the MCFA decanoic acid (10:0) might addition-
ally have neuroprotective effects by directly affecting oxidative stress.
Decanoic acid (10:0) administrated in the form of PC10:0/10:0 significantly reduced ROS levels compared 
to solvent, the PC-backbone l-α-Glycerophosphorylcholine or PC20:0/20:0 containing the LCFA arachidic acid 
(20:0). This demonstrates the observed effects to be due to the fatty acid chain length and not to the choline head 
group or the glycerophosphoric acid. Liposomes containing the used PCs have been shown to be taken up by cells 
in an endocytosis-like manner in nearly equal amounts irrespective of differences in their fatty acid acyl-chain 
composition. The supplemented PCs are either incorporated into cellular membranes, which might affect mem-
brane structure and fluidity, or hydrolyzed by phospholipases A to lysolipids and  FFAs42 serving as cellular signal 
molecules, essential energy sources or precursors of ketones. Under the chosen experimental conditions there 
seems to be no enhanced metabolism of decanoic acid (10:0) derived from PC10:0/10:0 into ketones. The level 
of βHB, the most abundant ketone body in  mammals12, was found to be unaffected by the different treatments. 
This observation indicates the reduction of oxidative stress in cells treated with PC10:0/10:0 to be independent of 
ketogenesis. Reduction of ROS in this experimental setup seems to be due to direct effects of decanoic acid (10:0). 
In line with this, a recent publication by Wang et al. provided evidence that a MCT-enriched diet administrated 
to aged rats has cognition-enhancing properties without altering cerebral ketone  levels24.
Accumulation and release of extracellular  H2O2 was measured by using the highly specific and sensitive 
Amplex Red  assay32,43, while the intracellular ROS measurements were performed by utilizing CellROX Green. 
This dye has been reported to represent rather a  O2•− detector than a general ROS indicator. It does not directly 
react with  H2O244,45. In conclusion our data suggest that PC10:0/10:0 reduces the levels of both intracellular 
 O2•− and extracellular  H2O2 (Fig. 5).  O2•− is largely generated by the mitochondrial electron transport chain and 
by the activity of NOX transmembrane proteins. Cytosolic SOD1 and mitochondrial SOD2 rapidly dismutate the 
intracellular  O2•− to  H2O2, which is further detoxified by enzymes such as GPx and catalase (Fig. 5). In line with 
the data published by Hughes et al.35, the respective measurement of the enzyme activities revealed a significant 
elevation of catalase activity in SH-SY5Y cells treated with PC10:0/10:0. Catalase converts  H2O2 into oxygen 
plus  water46. The remaining  H2O2 diffuses freely or facilitatedly into the extracellular  compartment5. Hence, the 
catalase-stimulating effect of PC10:0/10:0 in SH-SY5Y cells might explain the reduced  H2O2 release in these 
cells pretreated with PC10:0/10:0. However, PC10:0/10:0 seems to affect also the intracellular  O2•− concentration 
and in Neuro2a cells the  H2O2 release without significantly altering catalase activity. This suggests additional 
PC10:0/10:0-affected mechanisms regulating cellular ROS levels, for example mitochondrial or NOX-dependent 
 O2•− generation. Further research is needed to analyse whether also ROS production is affected by PC10:0/10:0 
under the chosen conditions and to elucidate the underlying mechanism of action. Decanoic acid (10:0) has been 
shown to modulate mitochondrial function in neuroblastoma cells. Hughes et al. found a marked increase in the 
mitochondrial citrate synthase, complex I activity and mitochondrial content in SH-SY5Y cells after exposure 
to 250 µM decanoic acid (10:0), indicating that mitochondrial  O2•− generation might be altered by this fatty 
acid. Interestingly, the ketone bodies βHB and AcAc also did not influence the impact of decanoic acid (10:0) 
on citrate synthase  activity35. Other authors showed an increase in mitochondrial respiration in mouse skeletal 
muscle along with a reduced  H2O2 production under a MCFA-rich diet compared to both LCFAs-enriched and 
Figure 5.  Schematic overview of the cellular generation and detoxification of  O2•− and  H2O2 including 
the observed effects of decanoic acid (10:0). The mitochondrial electron transport chain and NOX activity 
are the major cellular sources of  O2•−, which is rapidly converted to  H2O2 by distinct SODs (mitochondrial 
SOD2, cytosolic SOD1, extracellular SOD3). In contrast to other NOX isoenzymes generating  O2•−, NOX4 
predominatly releases  H2O2.  H2O2 diffuses across cellular membranes and is intracellularly detoxified by 
antioxidant enzymes such as GPx and catalase. Decanoic acid (10:0) administered in the form of PC10:0/10:0 
reduces the intracellullar ROS level with  O2•− probably representing the major detected ROS species. 
Additionally, the steady state level of extracellular  H2O2 as well as  H2O2 release is decreased in cells treated 
with PC10:0/10:0. The latter effect might be at least partially based on an upregulation of catalase activity 
independent of alterations in CAT gene expression. Figure was created using CorelDRAW Graphics Suite 2020.
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control chow. In the same study MCFA (200 µM)-treated C2C12 myotubes displayed increased mitochondrial 
oxidative capacity and less oxidative stress compared to cells treated with  LCFAs47. Generally, the biological effects 
of fatty acids are mediated by their integration into cellular membranes and their function as signal molecules, 
amongst others. Their incorporation into membrane phospholipids alters the biophysiological properties of cel-
lular membranes such as their fluidity and structure. This has been shown for PUFAs and decanoic acid (10:0) 
in low micromolar concentrations, likely resulting in a modulating effect on the activity of membrane enzymes, 
receptors, channels, and  transporters48–50. Therefore, we speculate that for example the activity of membrane-
associated NOX and thus  O2•− and  H2O2 generation is affected by PC10:0/10:0-treatment. Preferential mediators 
sensing and transducing FFA signals in neuronal cells are G protein-coupled receptors in the plasma membrane 
known as Free Fatty Acid Receptors (FFARs), cytosolic Fatty Acid-Binding Proteins (FABPs) and the family of 
nuclear PPARs including PPARγ, which is directly activated by decanoic acid (10:0)51,52. The observation that the 
reduction of  H2O2 release by PC10:0/10:0 depends on a pretreatment of the cells for more than 30 min, makes 
the rapid activation of G protein-induced cascades unlikely as mode of action of PC10:0/10:0. In contrast, an 
impact of PC10:0/10:0-derived decanoic acid (10:0) on transcription factors regulating genes associated with 
ROS generation and detoxification is conceivable. A similar mode of action has been reported for PUFAs, which 
stimulate the expression of several antioxidant target genes via an NF-E2-related factor 2 (NRF2)-dependent 
 mechanism53,54. Interestingly, Hughes et al. showed the decanoic acid (10:0)-mediated increase in catalase activ-
ity in SH-SY5Y cells to be completely prevented in the presence of the PPARγ antagonist BADGE (25 µM)35. 
In contrast, we show the PC10:0/10:0-mediated reduction in  H2O2 release to be unaffected by the inhibition of 
PPARγ or protein biosynthesis in the same cell line. Possible explanations for these divergent results include 
differences in the concentrations (250 µM decanoic acid vs. 10 µM PC10:0/10:0) and in the administration (FFA 
vs. fatty acid attached to PC) of the supplemented fatty acids. Although two different PPARγ antagonists were 
used in the present study revealing similar results, it should be mentioned that also the concentration of BADGE 
differed (25 µM vs. 5 µM). Further, we found catalase gene expression in SH-SY5Y cells to be unaffected by the 
treatment with PC10:0/10. Altogether our data indicate that the PC10:0/10:0-mediated reduction of  H2O2 release 
in SH-SY5Y cells is neither due to an activation of PPARγ nor to alterations in gene expression or the synthesis 
of new proteins in general. It might be at least partially based on an upregulation of catalase activity, which 
seems to be independent of alterations in CAT gene expression. In addition to the regulation of catalase at the 
transcriptional and post-transcriptional level, the enzyme has been reported to be regulated by post-translational 
modifications such as phosphorylation and  ubiquitination55.
Besides reducing the basal steady-state ROS level, PC10:0/10:0 increased the survival of SH-SY5Y cells 
exposed to  H2O2-induced oxidative stress. In line with this, Nafar et al. reported the pretreatment of primary 
cortical neurons with either CO or caprylic acid (8:0) (20 µM) or lauric acid (12:0) (50 µM) to protect these 
neurons from Aβ-induced toxicity. The exposure to Aβ-peptides resulted in an increase of intracellular ROS. 
The pretreatment of the cells with CO significantly attenuated  this25. However, the authors did not analyse 
whether the latter effect is due to MCFAs or rather to the polyphenol content of CO, which is known to have 
antioxidative and anti-inflammatory  properties56. The results of our study indicate the ROS-reducing effects of 
CO described in the study by Nafar et al.25 to be at least partially mediated by MCFAs and not exclusively by 
secondary plant ingredients.
In summary, an upregulation of catalase activity in neuronal cells by the MCFA decanoic acid (10:0) has 
been previously shown. Our study presents the novel finding that this, probably in combination with addi-
tional cellular mechanisms, results in the reduction of oxidative stress and in the attenuation of  H2O2-induced 
cell death. Importantly, these effects seem to be independent of the MCFA metabolization into ketone bodies. 
Thus, besides secondary plant ingredients, MCFAs might substantially contribute to the neuroprotective and 
cognition-enhancing effects of CO. Similarly, the beneficial effects of MCTs for cognitively impaired patients 
might not only be based on increased levels of circulating ketones, but also on the individual antioxidative effects 
of MCT-derived MCFAs. Latter are able to cross the blood–brain-barrier57,58 and might play a role in promoting 
neuronal health. In addition to various other health effects caused by MCFA intake, also detrimental effects for 
the myocardium have been reported after excessive MCFA  consumption59–61. Thus, further studies are needed 
to assess the potential of MCFAs for pharmacological and/ or nutritional interventions.
Experimental procedures
Preparation of lipids. 1,2-Didecanoyl-sn-glycero-3-phosphocholine (PC10:0/10:0), 1,2-Di-arachidoyl-
sn-glycero-3-phosphocholine (PC20:0/20:0) and l-α-Glycerophosphorylcholine were acquired from Sigma 
Aldrich (Munich, Germany). Due to the limited solubility of PC20:0/20:0, both phospholipids and L-α-
Glycerophosphorylcholine were dissolved in pre-warmed (37 °C) EtOH to a final concentration of 5 mM by 
vortexing and subsequent sonification for 10 min.
Cell culture and treatments. Human (SH-SY5Y) and murine (Neuro2a) neuroblastoma cells were main-
tained in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% FCS, 8.25 mM glucose, 1% non-essential 
amino acid solution, 4 mM l-glutamine, 2 mM sodium pyruvate, penicillin (100 U/ml)/streptomycin (0.1 mg/
ml) and 0.05 mg/ml gentamicin in a humidified atmosphere containing 5%  CO2 at 37 °C. Cells were passed 
before reaching confluence by detachment with trypsin/EDTA.
Incubation of cells with phospholipids and l-α-Glycerophosphorylcholine was performed as described 
 earlier62,63. Briefly, the concentration of FCS was reduced to 0.1% during the treatments in order to reduce the 
lipid content of the cell culture medium as well as cell proliferation. Cells were kept in FCS-reduced and phenol 
red–free culture medium (DMEM/ 0.1% FCS) for 6 h prior to the treatments. Then pre-warmed (37 °C) DMEM/ 
0.1% FCS was supplemented with phospholipids (10 µM if not stated otherwise), l-α-Glycerophosphorylcholine 
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(10 µM) or the solvent EtOH (0.2%) in glass vials under continuous vortexing and incubated on the cells for 18 h 
unless specified differently. 5 µM BADGE, 5 µM GW9662, 20 µM cycloheximide, 2 µM puromycin or dimethyl 
sulfoxide (DMSO) as solvent control were added the incubation medium for the co-treatment of cells with 
phospholipids and these inhibitors.
Measurement of extracellular  H2O2 using Amplex Red. Cells were seeded on black 96-well plates 
(2 ×  104 Neuro2a cells/ well, 3 ×  104 SH-SY5Y cells/ well) and treated as described above.
For determination of  H2O2 accumulating in the medium during the treatment period, 50 µl conditioned cell 
culture supernatant of each well were transferred to a new 96-well plate and supplemented with 5 µM Amplex 
Red (Cayman Chemical, Ann Arbor, USA) and 0.01 U/ml HRP (Thermo Fischer Scientific, Schwerte, Germany). 
A potential interference between the added agents and the HRP-catalyzed reaction between Amplex Red and 
 H2O2 was analyzed by repeating this experiment in a cell-free system utilizing freshly prepared DMEM/0.1% 
FCS + phospholipids (10 µM) or solvent in the presence of supplemented  H2O2 (0.000007%).
For measuring the  H2O2 freshly released by pretreated cells, the supernatant was removed and 50 µl of Amplex 
Red reaction mixture (5 μM Amplex Red and 0.01 U/ml HRP in phenol red-free DMEM/0.1% FCS) was added 
to each well.
The fluorescence signal of resorufin was determined at an excitation wavelength of 530 ± 17 nm and an emis-
sion wavelength of 590 ± 17 nm for 16 min (120 s (seconds) intervals) at 37 °C under light exclusion in a  Safire2 
Fluorometer (Tecan, Crailsheim, Germany). The increase of fluorescence over time was calculated for each well 
and used for further data analysis.
Measurement of intracellular ROS using CellROX Green Reagent. After pretreatment of the cells 
(2 ×  104 Neuro2a cells/ well, 3 ×  104 SH-SY5Y cells/ well) as described above, the supernatant was removed 
and cells were gently washed with prewarmed (37 °C) Ringer’s solution (130 mM NaCl, 2.4 mM KCl, 2.5 mM 
 CaCl2 × 2  H2O, 1.3 mM  MgCl2 × 6  H2O, 10 mM Hepes, 8.25 mM glucose, pH 7.4). Afterwards CellROX Green 
(Thermo Fischer Scientific, Schwerte, Germany) (1:500/ Ringer’s solution) was added to the cells and resulting 
fluorescence was detected at an excitation wavelength of 485 ± 10 nm and an emission wavelength of 520 ± 10 nm 
for 15 min (180 s intervals) at 37 °C under light exclusion in a  Safire2 Fluorometer. The slope of fluorescence over 
time was calculated for each well and used for further data analysis.
Measurement of  H2O2‑induced cell death. To analyze possible protective effects of PC10:0/10:0 against 
 H2O2-induced cytotoxicity, SH-SY5Y cells were seeded on 96-well plates (3 ×  104 cells/ well) and co-incubated 
with phospholipids (10 µM) or solvent as described above along with 500 µM  H2O2 for 18 h. Then propidiumio-
dide, a dye labeling dead cells that have a compromised membrane integrity, was added in a final concentration 
of 10 µM. After 60 min incubation at 37 °C resulting fluorescence was measured at an excitation wavelength of 
510 ± 20 nm and an emission wavelength of 617 ± 20 nm in a  Safire2 Fluorometer. After the addition of Triton 
X-100 (0.1%) the signal of 100% dead cells in each well was determined and the percentage of dead and viable 
cells was calculated for each well.
Determination of total cell numbers. After determination of extracellular  H2O2 levels,  H2O2 release 
or intracellular ROS levels in black 96-well plates as described above and removement of the supernatant, cells 
were fixed with 4% formaldehyde/ phosphate buffered saline (PBS, 2.7 mM KCl, 1.8 mM  KH2PO4, 137 mM 
NaCl, 10.1 mM  Na2HPO4 × 2  H2O) for 15 min and rinsed with PBS. In order to measure the total number of 
cells in each well DAPI (Cayman Chemical, Ann Arbor, USA) (1 µg/ml in PBS + 0.1% Triton X-100) was added. 
Resulting fluorescence was detected at an excitation wavelength of 358 ± 15 nm and an emission wavelength of 
461 ± 15 nm in a  Safire2 Fluorometer.
Determination of cell viability. After the treatment with phospholipids (10 µM) or solvent the percent-
age of dead cells was assessed by fluorescent microscopy utilizing a DM IL LED microscope (Leica Microsys-
tems, Wetzlar, Germany) and a Retiga R6 camera (Teledyne Photometrics, Birmingham, UK). Cells were stained 
with Ethidium homodimer-1 (10 µM) (Abcam, Berlin, Germany) and DAPI (1 µg/ml) in Ringer’s solution for 
10 min in the dark. Ethidium homodimer-1 labels cells with compromised plasma membranes red after bind-
ing to DNA. Dead cells showing an overlay of the Ethidium homodimer-1 signal (excitation: 528 nm, emission: 
617 nm) and the DAPI signal (excitation: 358 nm, emission: 461 nm) were counted before 0.2% Triton X-100 
was added in order to determine the total number of DAPI-stained nuclei. Percentage of dead cells was calcu-
lated on the basis of the number of cells showing an overlay of the Ethidium homodimer-1 signal with the DAPI 
signal and the total number of DAPI-stained nuclei after addition of Triton X-100.
Measurement of βHB levels. The levels of the ketone body βHB in cell homogenates and in conditioned 
cell culture medium were determined by using the β-Hydroxybutyrate (Ketone Body) Colorimetric Assay Kit 
(item no. 700190, Cayman Chemical, Ann Arbor, USA) according to manufacturerʹs instructions with minor 
 modifications25,64. Absorbance was monitored in a  Safire2 Fluorometer. Afterwards the protein content of the cell 
homogenates was determined as described below.
Measurement of catalase, SOD and GPx activity. The enzymatic activities of catalase, SOD and GPx 
were determined by utilizing the Amplex Red Catalase Assay Kit (item no. A22180, Thermo Fischer Scientific, 
Schwerte, Germany), the Superoxide Dismutase Activity Assay Kit (item no. ab65354, Abcam, Berlin, Germany) 
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and the Glutathione Peroxidase Activity Assay Kit (item no. ab219926, Abcam, Berlin, Germany), respectively. 
Assays were performed according to manufacturer`s instructions with minor modifications. Resulting absorb-
ance or fluorescence was monitored in a  Safire2 Fluorometer. Afterwards the protein content of the samples was 
measured as described below.
Determination of protein concentration. Protein determination in samples and bovine serum albu-
min (BSA) standards was carried out using bicinchoninic acid (BCA) according to Smith et al.65. Absorbance 
was measured at a wavelength of 560 nm in a  Safire2 Fluorometer.
RT‑PCR. Total RNA was extracted by the use of TRIzol Reagent (Thermo Fischer Scientific, Schwerte, Ger-
many). Reverse transcription of RNA was carried out with the RevertAid H Minus First Strand cDNA Synthe-
sis Kit (item no. K1631, Thermo Fischer Scientific, Schwerte, Germany). RT-PCR was performed by utilizing 
KAPA SYBR FAST (Sigma Aldrich, Munich, Germany) and a CFX Connect Real-Time PCR Detection System 
(Bio-Rad Laboratories, Feldkirchen, Germany). Results were normalized to β-actin or TATA-binding protein 
gene expression (ACTB, TBP) and changes in catalase (CAT) gene expression were calculated by using the  2−
(ΔΔCt)  method66. The following primer sequences were used (Sigma Aldrich, Munich, Germany): CAT primer 
pair 1: 5′-GCT GAG AAG CCT AAG AAT GCG-3′ and 5′-GAT GAG CGG GTT ACA CGG AT-3′, CAT primer pair 2: 
5′- ATT CGA TCT CAC CAA GGT TTG-3′ and 5′- CTT GGG TCG AAG GCT ATC TG-3′, ACTB: 5′-CTT CCT GGG 
CAT GGA GTC -3′ and 5′-AGC ACT GTG TTG GCG TAC AG-3′, TBP: 5′-CGG AGA GTT CTG GGA TTG T-3′ and 
5′-GGT TCG TGG CTC TCT TAT C-3′.
Statistical analyses. Statistical analyses were performed using Origin Pro 2020b software (OriginLab Cor-
poration).
For the measurements of extracellular  H2O2 levels,  H2O2 release, intracellular ROS levels and  H2O2-induced 
cell death as well as for the subsequent determination of total cell numbers in the corresponding wells, the 
mean of 3–4 Wells was considered as one independent experiment (n). Accordingly, these data are presented 
as mean ± standard error of the mean (SEM). All other data are outlined as mean ± standard deviation (SD). 
Shapiro–Wilk test and Levene’s test were used for testing normal distribution and homogeneity of variance, 
respectively. Statistical significance was determined by one-way analysis of variance (ANOVA) followed by post 
hoc testing using Tukey’s test, significance levels for p-values are as follows: * p ≤ 0.05; ** p ≤ 0.01 and *** p ≤ 0.001.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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